HomeCPRX • NASDAQ
add
Catalyst Pharmaceuticals Inc
Previous close
$15.46
Day range
$15.64 - $16.43
Year range
$11.55 - $17.50
Market cap
1.93B USD
Avg Volume
1.16M
P/E ratio
30.29
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 98.51M | 15.40% |
Operating expense | 56.28M | 55.26% |
Net income | 23.28M | -21.28% |
Net profit margin | 23.63 | -31.78% |
Earnings per share | 0.38 | 46.15% |
EBITDA | 36.56M | -13.39% |
Effective tax rate | 19.99% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 310.41M | 109.39% |
Total assets | 646.68M | 58.80% |
Total liabilities | 85.26M | 15.90% |
Total equity | 561.41M | — |
Shares outstanding | 118.12M | — |
Price to book | 3.25 | — |
Return on assets | 12.14% | — |
Return on capital | 14.18% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 23.28M | -21.28% |
Cash from operations | 31.92M | 164.50% |
Cash from investing | -199.00K | 99.88% |
Cash from financing | 141.05M | 94,563.76% |
Net change in cash | 172.78M | 215.07% |
Free cash flow | 25.43M | 115.92% |
About
Founded
2002
Headquarters
Website
Employees
167